SILK — Silk Road Medical Balance Sheet
0.000.00%
- $1.12bn
- $1.02bn
- $177.13m
- 57
- 17
- 93
- 56
Annual balance sheet for Silk Road Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 90.7 | 147 | 110 | 214 | 181 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8.6 | 9.07 | 11.8 | 18 | 23.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 112 | 173 | 143 | 255 | 241 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.13 | 5.64 | 12.9 | 14.5 | 14.6 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 137 | 179 | 157 | 270 | 265 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16.9 | 19.6 | 26.1 | 24.5 | 30.3 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 65.5 | 71.8 | 77.4 | 106 | 114 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 71.9 | 108 | 79.2 | 164 | 151 |
| Total Liabilities & Shareholders' Equity | 137 | 179 | 157 | 270 | 265 |
| Total Common Shares Outstanding |